FindTrial
Sign In

Clinical value of craniocerebral magnetic resonance imaging (NMR) in the diagnosis and treatment of delayed encephalopathy with acute carbon monoxide poisoning

Clinical value of craniocerebral magnetic resonance imaging (NMR) in the diagnosis and treatment of delayed encephalopathy with acute carbon monoxide poisoning

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015306
Enrollment
Unknown
Registered
2018-03-21
Start date
2018-03-22
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute carbon monoxide poisoning delayed encephalopathy

Interventions

Case series:Craniocerebral magnetic resonance imaging

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. acute carbon monoxide poisoning patients with delayed encephalopathy; 2. stable signs of life can complete craniocerebral MRI.

Exclusion criteria

Exclusion criteria: 1. patients with acute carbon monoxide poisoning had no delayed encephalopathy; 2. Vital signs were unstable or failed to complete the craniocerebral magnetic resonance imaging.

Design outcomes

Primary

MeasureTime frame
Craniocerebral magnetic resonance imaging;—

Countries

China

Contacts

Public ContactJian Xiangdong

Qilu Hospital of Shandong University

jianxiangdongvip@163.com+86 18560083182

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026